SEC Form 4 · accession 0001645627-17-000119
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 12, 2017
Accepted (ET)
Sep 14, 2017 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 12, 2017 | P | 5,000 | $0.0257 | A | 23,386,189 | D | |
| Common Stock | Sep 12, 2017 | P | 5,000 | $0.0256 | A | 23,391,189 | D | |
| Common Stock | Sep 12, 2017 | P | 5,000 | $0.0256 | A | 23,396,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0245 | A | 23,401,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0244 | A | 23,406,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0245 | A | 23,411,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0252 | A | 23,416,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0254 | A | 23,421,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0254 | A | 23,426,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0254 | A | 23,431,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0253 | A | 23,436,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0261 | A | 23,441,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0266 | A | 23,446,189 | D | |
| Common Stock | Sep 13, 2017 | P | 5,000 | $0.0279 | A | 23,451,189 | D |
Table II — derivative securities
No Table II lines on this filing.